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ABSTRACT
Background: 7KHOLYHULVLQYROYHGLQWK\URLGKRUPRQHFRQMXJDWLRQDQGH[FUHWLRQDVZHOODVWKHV\QWKHVLV
RIWK\URLGELQGLQJJOREXOLQ7HWUDLRGRWK\URQLQH7DQG7ULLRGRWK\URQLQH7UHJXODWHWKHEDVDOPHWDEROLF
UDWHRIDOOFHOOV
Method: 7KHVDPSOHRIWKLVUHVHDUFKZDVFROOHFWHGFURVVVHFWLRQDOO\RQSDWLHQWVZLWKOLYHUFLUUKRVLVEDVHG
&KLOG3XJKVFRUH8OWUDVRQRJUDSK\DQG77IUHHWK\R[LQH)7WK\URLGVWLPXODWLQJKRUPRQH76+OHYHOV
H[DPLQDWLRQVWRNQRZWKHGLIIHUHQFHEHWZHHQOLYHUFLUUKRVLVSDWLHQWVZLWK&KLOG3XJK$%DQG&ZLWKHQ]\PH
OLQNHGLPPXQRVRUEHQWDVVD\(/,6$PHWKRG
Results: 6WDWLVWLFDODQDO\VLVVKRZHGWKHUHDUHQRWIRXQGVLJQL¿FDQWGLIIHUHQFHVLQ77)776+OHYHOVLQ
SDWLHQWVZLWKRIWKHOLYHUFLUUKRVLVEDVHGRQWKH&KLOG3XJKVFRUH
Conclusion: 1RWIRXQGVLJQL¿FDQWGLIIHUHQFHVLQWK\URLGKRUPRQHOHYHOVDPRQJSDWLHQWVZLWKOLYHUFLUUKRVLV
Child-Pugh A, B, and C. 
Keywords: liYHU FiUUhRViV, WUiiRdRWh\URninH 7, WHWUaiRdRWh\URninH 7, IUHHWh\[RninH )7, Wh\URid 
VWiPulaWing hRUPRnH 76+, Child-Pugh VFRUH 
ABSTRAK
Latar belakang: Hati terlibat dalam konjugasi hormon tiroid dan ekskresi, serta sintesis tiroid binding 
globulin. 7etraiodoth\ronine 7 dan triiodoth\ronine 7 mengatur tingkat metabolisme basal dari semua 
sel. Perubahan T3 berkorelasi dengan tingkat keparahan penyakit dan sebagai prognosis sirosis hati. 
Metode: 'ilakukan dengan desain Fross seFtional terhadap  penderita sirosis hati berdasarkan ChildPugh 
sFore. 'ilakukan ultrasonogra¿ dan pemeriksaan kadar T3, T, Ireethyo[ine )T, thyroid stimulating hormone 
T6H untuk mengetahui perbedaan antara pasien sirosis hati dengan ChildPugh A, B dan C dengan metoda 
en]yme linked immune sorbent assay (/,6A.
 Hasil: 6eFara statistik tidak dijumpai perbedaan yang signi¿kan kadar T3,T,)T,T6H pada penderita 
sirosis hati berdasarkan ChildPugh sFore.
Simpulan: Tidak dijumpai perbedaan yang signi¿kan pada kadar T3,T,)T,T6H pada penderita sirosis 
hati berdasarkan ChildPugh sFore. 
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INTRODUCTION
The liver an important at thyroid metabolisms such 
as conjugation, excretion, peripheral deiodination, and 
synthesis thyroid-binding globulin (TBG). Over 60% of 
tetraiodothyronine (T4) is converted to triiodothyronine 
(T3) at the liver. This change represents biochemical 
changes due to liver dysfunction and pathological 
changes associated with organ damage.1
7KHVSHFLDOSXUSRVHRIWKLVUHVHDUFKLVWR¿QGLQJ
the demographic and clinical characteristics of liver 
cirrhosis patients, to investigate the differences in T3, 
T4, Freethyoxine (FT4), thyroid stimulating hormone 
(TSH) levels in patients with liver cirrhosis based on 
Child-Pugh score A, B, and C in the period between 
October-November 2017 and to determine the effects 
of changes in thyroid hormone in patients with liver 
cirrhosis.
METHOD
This is a cross-sectional descriptive analytic 
study which was conducted at October-November 
2017 in H Adam Malik General Hospital Medan on 
40 hospitalized liver cirrhosis patients according 
WR&KLOG3XJK VFRUH$OO RI WKHP IXO¿OOV LQFOXVLRQ
and exclusion criteria and blood samples were liver 
function tests (aspartate aminotransferase/AST, 
alanine aminotransferase/ALT, serum albumin, serum 
bilirubin, viral markers of hepatitis, thyroid function 
T3, T4, FT4, TSH using enzyme linked immune 
sorbent assay (ELISA) and ultrasonography (USG) 
of the abdomen.
SPSS version 22 (SPSS Inc.,Chicago) was used for 
the analysis. The data were analysed using unpaired 
QXPHULFDOFRPSDUDWLYHDQDO\WLFZLWKFRQ¿GHQFH
interval. Data in an analysis using Kruskal Wallis 
test with the power of study is 90%. To assess the 
correlation between T3, T4, FT4, and TSH with the 
liver function using Spearmen correlation test with a 
VLJQL¿FDQFHOHYHOVVHWDWS
RESULTS
In this study, the subjects are liver cirrhosis 40 patients. 
The results of this research are explained by the following 
tables. Table 1 shown as many as 22 men (55%) and 
women 18 (45%) with an average age of subjects was 
Table 2. Laboratory test results
Laboratorium n = 40
Aspartate aminotansferase/AST (mg/dL) 40,50 (8 - 311)b
Alanine aminotransferase/ALT (mg/dL) 33,50 (8 - 577)b
Alkaline phospatase/ALP (mg/dL) 85 (20 - 467)b
Billirubin direk (mg/dL) 1,60 (0,10 - 19)b
Billirubin total (mg/dL) 3,50 (0,20 - 29,80)b
Albumin (mg/dL) 2,20 (1,40 – 3,90)b
Thyroid stimulating hormone/TSH (μIU/mL) 1.57 (0,01- 7,57)b
Triiodothyronine (T3) (ng/mL) 0,51 (0,24)a
Tetraiodothyronine (T4) (μg/dL) 4.84 (1,19-18,02)b
Freethyoxine (T4) (ng/dL) 0,90 (0,40-10,99)b
a Numerical data, normal distribution: mean (standard deviation) 
b Numerical dat a, abnormal distribution: median (minimum-maximum) 
47.43 years. Serology results showed 22 people (55%) 
positive subjects of hepatitis B, only 1 person (2.5%) 
subjects with hepatitis C, the rest did not found the virus. 
Some subjects (50%) had a history of consuming alcohol 
and 27 (67.5%) subjects with Child-Pugh C. 
Table 1. Study subjects characteristics (n = 40)
Characteristics of the subject n (%) 
Gender, n (%)  
Man 22 (55) 
Women 18 (45) 
Age, average (SD), year 47.43 (13.72)a 
Body mass index, the mean (SD), kg/m2 21.78 (4.12)b
Tribe, n (%)  
Acehnese 1 (2.5) a 
Bataknese 20 (50) 
Javanese 5 (12.5) 
Karonese 3 (7.5) 
Melayunese 10 (25) 
Padangnese 1 (2.5) 
Roughing, n (%)  
Housewife 11 (27.5) a 
Civil servants 3 (7.5) 
Employee 7 (17.5) 
Farmer 19 (47.5) 
Etiology, n (%)  
Hepatitis B 22 (55) a 
Hepatitis C 1 (2.5) 
Non-B Non-C 17 (42.5) 
Child-Pugh, n (%)  
A 6 (15) a 
B 7 (17.5) 
C 27 (67,5) 
a Categorical Data : n (%); b Mean (SD)
Table 2 shows show median value (min-max), 
laboratory result of liver and thyroid function. Median 
(min-max) AST is 40.50 (8-311). Median (min-max) 
ALT is 33.50 (8 - 577), Median (min-max) ALP is 85 
(20-467). Median (min-max) Billirubin direct is 1.60 
(0.10-19). Median (min-max) The total billirubin 
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is 3.50 (0.20-29.80). Median (min-max) albumin 
is 2.20 (1.40-3.90). Median (min-max) globulin is 
3.40 (0.85-5.30). Median (min-max) PT is 1.40 (0.83 
-4.12). Median (min-max) TSH is 1.57 (0.01-7.57). 
The median (min-max) T3 is 0.46 (0.25-1.22). Median 
(min-max) T4 is 4.84 (1.19-18.02). The median (min-
max) FT4 is 0.90 (0.40-10.99). 
Table 3 shows the six markers of liver function only 
DOEXPLQDQG37KDGDVLJQL¿FDQWFRUUHODWLRQZLWKRQH
RIWKHWK\URLGKRUPRQH7S$OEXPLQKDVD
PRGHUDWHO\VLJQL¿FDQWFRUUHODWLRQS DQGLV
positive (r = 0.415) with T4, meaning an increase in 
albumin levels will be followed by an increase in T4 
levels.
DISCUSSION
 From the results of greater than that of 22 patients 
(55%) and 18 (45%). The ratio between men and 
women is 1.2: 1. This result is in accordance with 
previous studies. the number of men suffering from 
cirrhosis was greater than that of 22 patients (55%) and 
18 (45%). The ratio between men and women was 1.2: 
1. In a study conducted by Patira et al in USA in 2017 
reported that more men had liver cirrhosis (78%) in the 
United States.8 While the study of Joeimon J L et al in 
2017 in Indian reported the majority of patients with 
liver cirrhosis were male (72%).3 El-Feki et al reported 
that 66.7% of liver cirrhosis in Egypt were male.4 While 
the study by Rey I (2012) in Medan reported 72.5% of 
subjects with liver cirrhosis were male.5
The average liver cirrhosis patients in this study 
DJHG \HDUVZKLFK LV FODVVL¿HG DV SURGXFWLYH
age. The mean age in this study also did not differ 
from previous studies. Studies by Mobin et al in 2016 
in Pakistan reported an average age of 50.57 years 
of liver cirrhosis patients.6 While Wang et al in 2016 
LQ&KLQDUHSRUWHGDQDYHUDJHDJHRI\HDUVRI
liver cirrhosis patients.7 Rey I et al in 2012 in Medan 
reported the mean age of patients with age-bearing 
liver cirrhosis was 50, 95 years.5
In this study, the most etiological causes of cirrhosis 
of the liver are hepatitis B 22 (55%), hepatitis C 1 
(2.5%) and Non B Non C 17 (42.5). In contrast to 
the results of a study by Joeimon J L et al in 2017 in 
India in 111 patients it was reported that the etiology 
of most causes of cirrhosis were 64 patients with 
ethanol, hepatitis B 21 patients, hepatitis C 5 patients 
and autoimmune 5 patients.3 The results study of 
Patira et al in 2017 in India reported that the most 
aetiological causes of cirrhosis were alcohol (70%) 
patients, hepatitis B 13 (26%) patients and hepatitis 
C 2 (4%) patients.8 The results of Khean et al in 2011 
in Malaysia reported that the most aetiological causes 
of cirrhosis were hepatitis B 212 (46.1%) patients, 
hepatitis C 8 5 (18.5%) patients, 58 patients (12.6%), 
Kryptogenic 71 (15.4%) patients, 58 alcohol (12.6%) 
patients and autoimmune 9 (2%) patients.9
The majority of the subjects included Child-Pugh C 
27 (67.5%) patients. This is consistent with a study by 
Verma et al reported in 2017 in India that 102 patients 
with Child-Pugh C 56.8% (n = 58), Child-Pugh B 
39.8% (n = 40) and Child-Pugh A 3.9% (n = 4). This 
suggests that most subjects have advanced stages with 
decompensated liver cirrhosis.11
 ,Q WKLV VWXG\ WKHPHDQ7VKRZVQRVLJQL¿FDQW
correlation between with Child-Pugh Child-Pugh score 
Table 3. Correlation of Triiodothyronine (T3), Tetraiodothyronine 
(T4), Freethyoxine (FT4), thyroid stimulating hormone (TSH) 
and liver functions
p r
Aspartate aminotransferase (AST) T3 0,400 0,137
T4 0,982 0,004
FT4 0,421 0,131
TSH 0,265 0,180
Alanine aminotransferase (ALT) T3 0,319 0,162
T4 0,202 0,206
FT4 0,263 0,181
TSH 0,690 0,065
Alkaline phospatase (ALP) T3 0,837 0,034
T4 0,834 -0,034
FT4 0,819 -0,037
TSH 0,423 0,130
Direct billirubin T3 0,723 0,058
T4 0,242 -0,189
FT4 0,913 -0,018
TSH 0,729 -0,057
Total billirubin T3 0,920 0,016
T4 0,113 -0,254
FT4 0,388 -0,140
TSH 0,879 -0,025
Albumin T3 0,509 0,108
T4 0,008* 0,415
FT4 0,218 0,199
TSH 0,516 0,106
*p < 0,05
Table 4 shows Correlation of Differences Levels 
T3, T4, FT4, TSH Based on Child-Pugh Score.
Tabel 4. Correlation of differences levels Triiodothyronine (T3), 
Tetraiodothyronine (T4), Freethyoxine (FT4), thyroid stimulating 
hormone (TSH) based on Child-Pugh score
CP A 
(n=6)
CP B 
(n=7)
CP C (
n=27) p
Triiodothyronine
(T3)
0,47 
(0,46)
0,54 
(0,19)
0,51 
(0,18)
0,861
Tetraiodothyronine
(T4)
8,71 
(2,95)
4,80 
(3,08)
5,85 
(3,76)
0,063
Freethyoxine 
(FT4)
0,97 
(0,57)
2,21 
(3,89)
1,14 
(0,97)
0,827
thyroid stimulating
hormone (TSH)
1,49 
(1,78)
2,26 
(1,67)
1,65 
(1,41)
0,315
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(p = 0.861). The highest T3 levels were found in Child-
Pugh B with a mean of 0.54 and the lowest in Child-
Pugh A with a mean of 0.47. This is in accordance with 
research Eshraghian et al in 2014 in Iran reported that 
patients with liver cirrhosis had low T3.12 This is due 
to a decrease in D1 activity and the impaired hepatic 
T4 conversion when the conversion becomes T3. 
This is also in accordance with the study of Mansour 
et al in 2012 in Egypt who reported that in liver 
cirrhosis occurs binding protein disorders, adaptive 
hypothyroidism occurs to reduce BMR in hepatocytes 
and disruption of total body protein availability due to 
malnutrition and liver defense mechanisms.13
 ,Q WKLV VWXG\ WKHPHDQ7VKRZVQRVLJQL¿FDQW
correlation between with Child-Pugh score (p = 0.063). 
The highest T4 levels were found in Child-Pugh A with 
the mean of 8.71 and lowest on Child-Pugh B with the 
mean of 4.80. According to research by Antonelli et al 
in 2004 that low T4 levels in patients with advanced 
liver cirrhosis are due to decreased metabolism of T4 
and increased T3. This probably depends on the extent 
of hepatocellular damage and repair in liver function 
so that T4 can be a prognostic index.11 Malik R et al 
in 2002 in explains that the liver plays a major role in 
the conversion of T4 in the periphery.14
,QWKLVVWXG\WKHPHDQ7)VKRZVQRVLJQL¿FDQW
correlation between with Child-Pugh score (p = 0.827). 
The highest FT4 levels were found in Child-Pugh B 
with the mean of 2.21 and lowest in Child-Pugh A 
with the mean of 0.97. Based on the research Malik 
R et al in 2002 that the normal FT4 levels in patients 
chronic liver disease.14 However, this is in contrast 
to Antonelli et al in 2004 reporting a significant 
increase in FT4 in cirrhosis groups. This is due to the 
different geographic distribution, population genetic 
background, and environmental factors, such as iodine 
intake or infectious agents.11 Elkabbany et al in 2012 
UHSRUWHGWKDWWKHUHZDVQRVLJQL¿FDQWGLIIHUHQFHLQ)
T4 levels in patients with liver cirrhosis.16
,QWKLVVWXG\WKHPHDQ76+VKRZVQRVLJQL¿FDQW
correlation between with Child-Pugh score (p = 0.315). 
The highest TSH levels were found in Child-Pugh B with 
the mean of 2.26 and the lowest in Child-Pugh A with 
an average of 1.49. Based on the results of TSH found 
that experienced 80% euthyroid and 20% hypothyroid. 
This is consistent with the research of Antonelli et al 
in 2009 that abnormalities in TSH secretion are caused 
by presence hypothalamic-pituitary dysfunction in 
advanced liver disease and body adjustment of liver 
cirrhosis and basal metabolic rate savings, decreased 
dopaminergic as a consequence of the accumulation 
of false neurotransmitters that may be responsible for 
increasing basal TSH concentrations, as dopamine has 
been shown to have an inhibitory effect on regulation 
TSH secretion.11 This is also consistent with the study 
of Moustafa et al in 2009 who reported that elevated 
serum TSH levels in decompensated cirrhosis patients 
were compared with compensated cirrhosis patients.15 
This is in accordance with Ghanaei et al in 2014 that 
TSH levels are higher in patients with cirrhosis with 
Child-Pugh score C. There is a positive correlation 
between TSH levels and Child-Pugh score scores in 
patients with liver cirrhosis.17
 The limitations of this study are it is this study is not 
to consider the geographical area of  research subjects 
such as living in mountainous areas affecting iodine 
LQWDNH1RW IRXQG VLJQL¿FDQW GLIIHUHQFHV LQ77
FT4, TSH levels in patients with cirrhosis of the liver 
based on Child-Pugh score. Level of T3, FT4, and TSH 
can not correlation with the severity of liver disease.
CONCLUSION
In conclusion, that thyroid hormone levels did 
QRWGLIIHUHQW VLJQL¿FDQWO\DPRQJSDWLHQWVZLWK OLYHU
cirrhosis Child-Pugh A, B and C. 
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